Home
About
Overview
Sharing Data
ORCID
Help
History (25)
Clinical decision support improves physician guideline adherence for laboratory monitoring of chronic kidney disease: a matched cohort study.
Long-term remission of extramedullary relapse from acute promyelocytic leukemia after treatment with arsenic trioxide, intrathecal chemotherapy, and brain irradiation.
Cellular and molecular biology of Alzheimer's disease and animal models.
The program of protein synthesis during heterocyst differentiation in nitrogen-fixing blue-green algae.
Simvastatin reverses cardiac hypertrophy caused by disruption of the bradykinin 2 receptor.
See All 25 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Simvastatin reverses cardiac hypertrophy caused by disruption of the bradykinin 2 receptor.
Simvastatin reverses cardiac hypertrophy caused by disruption of the bradykinin 2 receptor. Can J Physiol Pharmacol. 2008 Sep; 86(9):633-42.
View in:
PubMed
subject areas
Animals
Blood Pressure
Cardiomegaly
Enzyme Inhibitors
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypertrophy, Left Ventricular
Mice
Mice, Knockout
Mitogen-Activated Protein Kinases
Myocytes, Cardiac
NG-Nitroarginine Methyl Ester
Nitric Oxide Synthase Type III
Phosphorylation
Platelet Endothelial Cell Adhesion Molecule-1
Receptor, Bradykinin B1
Receptor, Bradykinin B2
Signal Transduction
Simvastatin
Stroke Volume
Ultrasonography
authors with profiles
James Liao